Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02170233 · ClinicalTrials.gov registry record
SHOCK US STUDY: Fluid Responsiveness in Sepsis Measured by Ultrasonography
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 65
- Enrollment target
NCT02170233: Completed study, sponsored by Yale University.
NCT02170233 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02170233 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
The study aim is to examine point-of-care ultrasound findings, reliability, and ease of performance in association with fluid responsiveness for patients with severe sepsis and septic shock. The investigators propose a prospective observational research study of patients presenting to one of three Yale New Haven Hospital emergency departments, York Street Campus, St. Raphael's Campus, and Shoreline Medical Center who meet criteria for sepsis, severe sepsis or septic shock during their emergency department visit.
Primary Outcome
Ultrasound Measurement: Carotid corrected flow time in relation to cardiac output to assess fluid responsiveness.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-06 |
What the finished NCT02170233 record still lists
NCT02170233 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02170233 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02170233 about?
NCT02170233 is a clinical study titled "SHOCK US STUDY: Fluid Responsiveness in Sepsis Measured by Ultrasonography". The study aim is to examine point-of-care ultrasound findings, reliability, and ease of performance in association with fluid responsiveness for patients with severe sepsis and septic shock. The investigators propose a prospective observational research study of patients presenting to one of three Y...
What is the current status of trial NCT02170233?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2014-08. Estimated completion is 2016-06.
Who is sponsoring clinical trial NCT02170233?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia